Editor - Katalin Borbély | Medical University of Pecs and Kapos | 19020
ISSN 2472-016X

Journal of Orthopedic Oncology
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Katalin Borbély

Katalin Borbély
Katalin Borbély
PET/CT Outpatient Department
Medical University of Pecs and Kaposvar Hungary
National Institute of Oncology


Katalin Borbély, MD, PhD, MedHab, DSc, Professor of Medical University of Pecs and Kaposvar, Hungary, Europe). She has board examinations in neurology, internal medicine, and nuclear medicine (Semmelweis University, Budapest). She did her PET training (tumors, movement disorders, epilepsy, and stroke) at NIH (Bethesda, MD, USA). Also, she worked for the Universities of Zürich, Klagenfurt, and Paris. She had a close scientific collaboration with Universities of Karolinska, Stockholm, and Aarhus. She worked for the National Institute of Neurosurgery (Budapest, 1985-2005), National Institute of Oncology (2005- ), University of Kaposvar (2011- ) (PET/CT, PET/MRI Centers). She was/is a supervisor and lecturer at several PhD courses (Eotvos Lorand University, Universities of Budapest, Pecs, etc.). She has over 70 publications, including highly cited articles (cit: over 840), books, chapters, over 300 lectures. She has a wide research, referees, and expert advisory activities. She is a member of several societies, editorial boards, etc. She has got over 10 awards since her schools.

Research Interest

Katalin Borbély’ primary research interests in different kind of neoplasia include novel PET biomarkers, tumor heterogeneity, the impact of PET/MR in oncology and neurology (tumors, dementia, and epilepsy).



Global Speakers in the subject

Global Experts in the subject